Early Access to Carfilzomib for Eligible Patients

Ever since Carfilzomib, made by ONYX Pharmaceuticals, began progressing through the clinical trials process from Phase I forward, it has been a regular topic of interest on the IMF Hotline.

On the subject of rainbows and earthworms

Reading about the newly re-discovered Rainbow Toad in Borneo reminded me of my January 27, 2011 post referencing Mae-Wan Ho's 

My Search for a Cure

At this month's Patient & Family Seminar in Dallas, TX, I posed this question to the panel of myeloma experts: "What myeloma research would you conduct if you were given $100 million?" Faculty member Dr.

Pages